Home >
Medicine Info >
FASTCLAV 125MG DRY SYRUP
Loading interface...

FASTCLAV 125MG DRY SYRUP

Manufactured byIpca Laboratories Pvt. Ltd.
ContainsCefuroxime (125 mg) + Clavulanic Acid (31.25 mg)
Description
FASTCLAV 125MG DRY SYRUP is a combination medicine used for treating a variety of bacterial infections of the upper and lower respiratory tract, urinary tract, and uncomplicated skin infections. This medicine is not recommended for use in infants less than 3 months of age.
QUICK LINKS:
Side effectsConcernsUsage

Side effects

Major & minor side effects for FASTCLAV 125MG DRY SYRUP

  • Diarrhea
  • Chills
  • Headache
  • Itching of vagina or genital area
  • Chest pain
  • Difficult or painful urination
  • Shortness of breath
  • Change in taste
  • Abdominal pain
  • Acid or sour stomach

Uses of FASTCLAV 125MG DRY SYRUP

What is it prescribed for?

  • Pharyngitis/Tonsilitis
  • Acute maxillary Sinusitis
  • Acute Bacterial exacerbations of chronic bronchitis
  • Secondary Bacterial infection of Acute Bronchitis
  • Skin and Skin Structure Infection
  • Uncomplicated urinary tract infections
  • Lyme disease
  • Acute Bacterial Otitis Media
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The peak effect of this medicine can be observed within 2 to 3 hours of administration of the dose.
  • How long do the effects of this medicine last?
    This effect of this medicine lasts for an average duration of approximately 4 to 8 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. If the medicine is used, the infant should be monitored closely for any undesired side effects.

Allergy

This medicine is not recommended for use in patients with a known allergy to cefuroxime, other beta-lactam antibiotics, clavulanic acid derivatives, or any other inactive ingredients present along with these medicines.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. If the medicine is used, the infant should be monitored closely for any undesired side effects.
General warnings

Clostridium difficile-associated Diarrhea

Discontinue the use of this medicine as per the doctor's instructions if severe diarrhea occurs after receiving this medicine. This medicine may cause an imbalance in the microbial flora of the large intestine, decreasing the gut-friendly bacteria and promoting the growth of a bacteria called Clostridium difficile, resulting in severe diarrhea.

Impaired kidney function

This medicine should be used with caution in patients with a pre-existing kidney disease due to the increased risk of severe adverse effects. Close monitoring of kidney function, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition.

Drug-resistance

Usage of this medicine without sufficient proof or suspicion of a bacterial infection should be avoided. Irrational dosing might fail in providing the benefits and even cause toxicity. It may also increase the risk of development of bacteria that are drug resistant.

Use in pediatrics

This medicine is not recommended for use in infants less than 3 months of age since the safety and efficacy of use are not clinically established.

Jarisch-Herxheimer reaction

This medicine may cause Jarisch-Herxheimer reaction in some patients when used for more than 7 days. The symptoms of this reaction may include fever, chills, headache, low blood pressure, increased heart rate, etc. This reaction is usually self-limiting and subsides with the resolution of infection.

Missed Dose

Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Amikacin

Chloramphenicol

Ethinyl Estradiol

Cholera Vaccine

Furosemide

Disease interactions

Colitis

This medicine should be used with extreme caution in patients having a history of gastrointestinal diseases, particularly colitis, since it may worsen the patient's condition. Report any incidence of severe diarrhea, abdominal pain, blood in stools, etc. to the doctor immediately. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Liver Disease

This medicine should be used with caution in patients with a history of liver diseases or a family history of liver diseases due to the increased risk of severe adverse effects. Close monitoring of liver function is recommended during treatment with this medicine. Report any undesired effects to the doctor on priority. Appropriate dose adjustments or replacement with a suitable alternative may be considered based on the clinical condition.

Seizure disorders

This medicine should be used with caution in patients with a history of seizure disorder or a family history of seizures due to the increased risk of recurrent seizures. Therapy should be discontinued if the patient experiences a seizure episode due to this medicine. Appropriate corrective measures and/or replacement with a suitable alternative may be necessary in some cases based on the clinical condition.
Food interactions
Information not available.
Lab interactions

Ferricyanide test

Inform the doctor if you are advised to have this test when you are undergoing treatment with this medicine. This medicine may result in false-negative results for this test. Alternative tests should be used for testing blood glucose based on the clinical condition.
This is not an exhaustive list of possible drug interactions. You should consult your doctor about all the possible interactions of the drugs you’re taking.
Take this medicine exactly as prescribed by the doctor. Do not take in larger or smaller quantities than recommended. This medicine can be taken with or without food. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Cefuroxime works by interfering with the bacterial cell wall formation. Clavulanic acid is effective against a specific species of bacteria that are resistant to other antibiotic medicines. Thus, the combination becomes effective against an extended range of bacteria.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Second generation cephalosporins, Beta-lactamase inhibitors

Schedule

Schedule H

[Internet]. 2017 [cited 21 February 2017]. Available from:

https://www.medicines.org.uk/emc/medicine/22534#PRODUCTINFO

Cefuroxime: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2017 [cited 21 February 2017]. Available from:

https://medlineplus.gov/druginfo/meds/a601206.html

DailyMed - cefuroxime axetil tablet [Internet]. Dailymed.nlm.nih.gov. 2017 [cited 21 February 2017]. Available from:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=faef39e9-d793-4191-a728-310f6fab759d

Clavulanate - DrugBank [Internet]. Drugbank.ca. 2018 [cited 27 February 2018]. Available from:

https://www.drugbank.ca/drugs/DB00766
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 5 Mar 2018

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.